Home
About
- Author Guidelines
- Editorial Board
Contact
Issue Archive
- 2017
- 2016
- 2015
Special Issues

Subscribe to Personalized Medicine in Oncology

To sign up for our e-mail newsletter or print publications, fill out the information below and click Subscribe.

Country

Print Edition

E-Newsletters & Communications

I have reviewed and consent to the terms of PMO's Privacy Policy, and PMO has my permission to retain my information in its database, and to forward pertinent communications to me.

PMO Interview with the Innovator Series
Conference Correspondent
Web Exclusives
- FDA Approvals, News & Updates
- Press Releases
Continuing Education
Videos

PMO Interview with the Innovator Series
Conference Correspondent
Web Exclusives
- FDA Approvals, News & Updates
- Press Releases
Continuing Education
Videos

Home
About
- Author Guidelines
- Editorial Board
Contact
Issue Archive
- 2017
- 2016
- 2015
Special Issues

Mark G Erlander, PhD

Chief Scientific Officer of bioTheranostics, Inc.

In the News

May 19, 2016

Two-pronged attack on chemotherapy-resistant leukemia cells

May 18, 2016

An Early Look at Research From the 2016 ASCO Annual Meeting

May 18, 2016

Drug against breast cancer is also highly potent against a frequent form of leukaemia

May 17, 2016

Improving natural killer cancer therapy: Study

linkedin
Connect with us

Keep up to date with all of our news! Sign me up!

By continuing to browse the site you are agreeing to our use of cookies.

Mark G Erlander, PhD

linkedin Connect with us

linkedin
Connect with us